Not applicableActive Not RecruitingNCT00069589What this trial is testingAlopecia Areata RegistryWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis+2 more M.D. Anderson Cancer Center 3,100
Testing effectiveness (Phase 2)Ended earlyNCT04517864What this trial is testingPLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATAWho this might be right forAlopecia Areata Pfizer 71
Testing effectiveness (Phase 2)Study completedNCT03315689What this trial is testingSafety and Pharmacokinetic Study of ATI-50002 in Subjects With Alopecia Universalis (AU) and Alopecia Totalis (AT)Who this might be right forAlopecia Universalis (AU)Alopecia Totalis (AT) Aclaris Therapeutics, Inc. 11
Large-scale testing (Phase 3)Active Not RecruitingNCT04006457What this trial is testingLong-Term PF-06651600 for the Treatment of Alopecia AreataWho this might be right forAlopecia Areata Pfizer 1,052
Testing effectiveness (Phase 2)WithdrawnNCT00746980What this trial is testingEfalizumab in the Treatment of Alopecia, Phase IIWho this might be right forAlopecia Totalis Northwestern University
Testing effectiveness (Phase 2)Study completedNCT02299297What this trial is testingStudy To Evaluate The Efficacy Of Tofacitinib In Moderate To Severe Alopecia Areata, Totalis And UniversalisWho this might be right forAlopecia Areata Columbia University 12
Not applicableStudy completedNCT04205214What this trial is testingA Randomised Control Trial of Integrative Cognitive Behavioural Therapy for AlopeciaWho this might be right forAlopecia City, University of London 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07406204What this trial is testingTofacitinib vs Methotrexate for Severe Alopecia Areata (TOFA-MTX-AA)Who this might be right forAlopecia AreataAlopecia Totalis (AT)Alopecia Universalis Hayat Abad Medical Complex, Peshawar 78
Large-scale testing (Phase 3)Study completedNCT00997815What this trial is testingThe Randomized Double-blind Placebo-controlled Trial of Intralesional Botulinum Toxin A Injection for Recalcitrant Alopecia Totalis and Alopecia UniversalisWho this might be right forRecalcitrant Alopecia TotalisRecalcitrant Alopecia Universalis Siriraj Hospital 20
Testing effectiveness (Phase 2)WithdrawnNCT03532958What this trial is testingPhase 2 Trial of BNZ-1 in Patients With Moderate to Severe Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Equillium
Testing effectiveness (Phase 2)Study completedNCT05589610What this trial is testingStudy of EQ101 in Adult Subjects With Moderate to Severe Alopecia AreataWho this might be right forAlopecia AreataAlopeciaAlopecia Totalis+1 more Equillium 36
Testing effectiveness (Phase 2)Looking for participantsNCT06747611What this trial is testingEvaluation of Microbiota Transplant Therapy in Patients With Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis University of Minnesota 40
Post-approval studies (Phase 4)Looking for participantsNCT07381556What this trial is testingCyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness StudyWho this might be right forAlopecia Areata(AA)Alopecia Areata (AA)Alopecia Totalis/Universalis+3 more Erasmus Medical Center 50
Not applicableAvailableNCT05522556What this trial is testingPre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)Who this might be right forAlopecia Areata Pfizer
Testing effectiveness (Phase 2)UnknownNCT04011748What this trial is testingClinical Application of Stem Cell Educator Therapy in Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Throne Biotechnologies Inc. 20
Testing effectiveness (Phase 2)Study completedNCT02812342What this trial is testingTopical Tofacitinib for the Treatment of Alopecia Areata and Its VariantsWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Yale University 10
Large-scale testing (Phase 3)Looking for participantsNCT06873945What this trial is testing2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataWho this might be right forAlopecia Areata Pfizer 550
Testing effectiveness (Phase 2)Study completedNCT03551821What this trial is testingOpen Label Study of ATI-50002 Topical Solution Administered to Adult Subjects With Eyebrow Loss Due to Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Aclaris Therapeutics, Inc. 1
Testing effectiveness (Phase 2)WithdrawnNCT04238091What this trial is testingClinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia AreataWho this might be right forAlopecia AreataAlopecia TotalisAlopecia Universalis Lindsey Bordone
Testing effectiveness (Phase 2)Ended earlyNCT03759340What this trial is testingATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), Alopecia Universalis (AU) and Alopecia Totalis (AT)Who this might be right forAlopecia AreataAlopecia UniversalisAlopecia Totalis Aclaris Therapeutics, Inc. 56